Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
Ainhoa Gómez-Lumbreras, Malinda Tan, Lorenzo Villa Zapata, Sabrina Ilham, Jacob Craig Earl, Daniel C. Malone
Topics & Concepts
MedicineLiraglutideSemaglutideBody mass indexQuality-adjusted life yearBupropionCost effectivenessInternal medicineDemographyDiabetes mellitusType 2 diabetesEndocrinologyPathologySociologyRisk analysis (engineering)Smoking cessationPharmacology and Obesity TreatmentDiabetes Treatment and ManagementBariatric Surgery and Outcomes